TrialFind
Saved trials
Back to results
Recruiting
Phase 2
A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease
NCT07322887
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
CTC Netherlands BV
Groningen, Netherlands
Contact
Nadir Ulu, MD, PhD
(+90) 5334510385
n.ulu@genilac.com
View on ClinicalTrials.gov
Official details
A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease — TrialFind